Preparation of HMME-Gd liquid fluorocarbon nanoparticles contrast agent and dual-mode imaging in vitro
返回论文页
|更新时间:2023-10-09
|
Preparation of HMME-Gd liquid fluorocarbon nanoparticles contrast agent and dual-mode imaging in vitro
Journal of Clinical Ultrasound in MedicineVol. 22, Issue 11, (2020)
作者机构:
1. 重庆医科大学附属第二医院超声科
2. 重庆医科大学附属第二医院眼科
3. 中国科学院大学重庆医院(重庆市人民医院)全科医学科
4. 重庆医科大学附属第二医院神经外科
5. 重庆市超声影学研究所
作者简介:
基金信息:
DOI:
CLC:
Published:2020,
Published Online:1 December 2020,
扫 描 看 全 文
Preparation of HMME-Gd liquid fluorocarbon nanoparticles contrast agent and dual-mode imaging in vitro. [J]. Journal of Clinical Ultrasound in Medicine 22(11).(2020)
DOI:
Preparation of HMME-Gd liquid fluorocarbon nanoparticles contrast agent and dual-mode imaging in vitro. [J]. Journal of Clinical Ultrasound in Medicine 22(11).(2020)DOI:
Preparation of HMME-Gd liquid fluorocarbon nanoparticles contrast agent and dual-mode imaging in vitro
Objective To prepare liquid fluorocarbon nanoparticles carrying HMME-Gd (HMME-Gd-PFPNPs) and observe the effect of ultrasound/MRI imaging capability in vitro. Methods Lipids cholesterol
hematoporphyrin monomethyl ether gadolinium (HMME-Gd) and perfluoropentane (PFP) were used as raw materials to prepare nanoparticles by membrane hydration and emulsification. The general physical properties were measured by optical microscopy
transmission electron microscopy and laser confocal microscope. The size and surface potential were analyzed by particle size analyzer. The encapsulation efficiency of HMME-Gd in HMME-Gd-PFPNPs was determined by UV-vis. The ultrasound (US)/magnetic resonance imaging (MRI) capability of HMME-Gd-PFPNPs was observed in vitro. Results HMME-Gd-PFPNPs were successfully prepared
which were regular in shape and uniform in size. They showed a black spherical structure under transmission electron microscopy. The size of HMME-Gd-PFPNPs was (250.27 ± 11.9) nm
the surface potential was (-26.17 ± 0.45) mV
and the encapsulation efficiency of HMME-Gd was (84.7 ± 0.35) %. As the concentration of HMME-Gd-PFPNPs increased
the MRI signal was significantly enhanced in vitro. Under low intensity focused ultrasound (LIFU) irradiation
the US imaging signal was significantly enhanced in vitro
which was positively correlated with the intensity of LIFU. Conclusion The liquid fluorocarbon nanoparticle contrast agent carrying HMME-Gd was successfully prepared and can be used for US/MRI dualmodal imaging in vitro.
Preparation of HMME-Gd liquid fluorocarbon nanoparticle contrast agent and study on dual-mode imaging in vitro
The application value of contrast-enhanced ultrasound in the evaluation of local thermal ablation of liver cancer and the analysis of the influencing factors of local tumor progression
Safety analysis of intravenous sulfur hexafluoride microbubble in abdominal ultrasonography
Application of contrast-enhanced ultrasound liver imaging reporting and data system in high-risk patients with alpha-fetoprotein- negative hepatocellular carcinoma
In Vitro Experimental Study of Drug-loaded Nanoparticles with Phase-changed Capability for Multimodal Imaging and Sonodynamic Therapy combined with Chemotherapy
Related Author
LUO Yuanli
QIAO Bin
CAO Jin
YUAN Xun
XIE Zhuoyan
YANG Anyu
HU Xinghua
ZHOU Zhiyi
Related Institution
重庆医科大学附属第二医院超声科
中国科学院大学重庆医院重庆市人民医院全科医学科
Department of Ultrasound,the Second Affiliated Hospital of Chongqing Medical University